Advertisement

Reactions Weekly

, Volume 1731, Issue 1, pp 197–197 | Cite as

Nivolumab/pembrolizumab

Autoimmune diabetes and autoimmune colitis: case report
Case report
  • 13 Downloads

Reference

  1. Lara KM, et al. Talimogene laherparepvec in combination with pembrolizumab leads to a complete response in a patient with refractory Merkel cell carcinoma. JAAD Case Reports 4: 1004-1006, No. 10, Nov 2018. Available from: URL: http://doi.org/10.1016/j.jdcr.2018.10.003 - USACrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2018

Personalised recommendations